China’s novel coronavirus vaccine, listed in the who list of emergency use!

Concerned about Fengxian big and small things, concerned about “Shanghai Fengxian” master! Who seals China’s novel coronavirus vaccine! On May 7 local time, who announced that a novel coronavirus vaccine from Sinopharm will be included in the WHO emergency use list, and this vaccine will become the sixth vaccine listed in the WHO emergency use list

.

Data chart: Xinguan vaccination

.

China News Agency reporter Li Jiaxian, who director general Tan Desai said at the same day’s press conference that the who has included a vaccine developed by China National Pharmaceutical Group China biological Beijing Institute of biological products in the list of emergency use, which meets the WHO standards on the safety, effectiveness and quality of the novel coronavirus vaccine

.

Tan Desai said that this novel coronavirus pneumonia vaccine implementation plan (COVAX) will enable the novel coronavirus vaccine to be purchased, and enhance the confidence of the relevant national drug regulatory agencies to approve the vaccine and speed up the import and vaccination of the national drug group

.

According to the available data, the WHO Advisory Group on immunization strategy recommends that adults over the age of 18 can receive two doses of Sinopharm novel coronavirus vaccine

.

According to the WHO standard, the novel coronavirus vaccine with an effective rate of more than 50%, preferably close to or higher than 70%, and good safety can be included in the emergency use list

.

Alejandro kravioto, chairman of the WHO immunization strategy advisory expert group, said at a press conference earlier that the vaccine data submitted by Sinopharm and Kexing clearly show that the protective efficacy of the vaccines of the two companies meets the requirements of who, and the data submitted by the two companies also show the safety of the two vaccines, They are not harmful to the human body

.

Who has authorized the use of several novel coronavirus vaccines, including the vaccine jointly developed by Pfizer and German biotechnology company, the vaccine jointly developed by AstraZeneca and Oxford University, and the vaccine developed by Johnson & Johnson’s Janssen Pharmaceutical Company

.

Chinese medicine vaccine is the first inactivated vaccine listed in who’s emergency use list

.

A new coronal vaccine developed by China Kexing company has also entered the final stage of who emergency use authorization assessment

.

Data picture: on March 8, a man was vaccinated with Sinopharm Xinguan vaccine in Maputo, Mozambique

.

According to Xinhua news agency, the World Health Organization (who) is conducting an emergency use authorization assessment on two vaccines in China

.

Once they are approved, a report published on the website of Nature magazine said, These two vaccines will help to fill the supply gap of the current “novel coronavirus vaccine implementation plan” and enable low-income countries to achieve large-scale vaccine distribution

.

The article published in the news section of the website of nature said that the “novel coronavirus vaccine implementation plan” intends to distribute 2 billion doses of vaccine to the world in 2021, but only about 50 million doses have been completed; In view of the current global vaccine supply is seriously limited, the demand for vaccines in China is very urgent

.

The demand for vaccines in China is huge, according to fildoxy kadley, an immunologist at the International Center for diarrhoeal disease research in Bangladesh

.

Kadley pointed out that the WHO approval process involves the evaluation of vaccine safety, effectiveness and production quality

.

Approved vaccines can be purchased by specialized agencies of the United Nations

.

In particular, the article points out that for many countries and regions, China’s vaccine is the only vaccine available

.

In Brazil, Turkey, Chile and other countries that are vaccinating with Chinese vaccines, local researchers have also seen the effectiveness of these vaccines in controlling the epidemic

.

Netizen: proud! According to the global times, many experts have advised India to accept China’s aid at a time when the epidemic situation in India is extremely severe

.

Jerome king, director of the Seoul based International Institute for vaccine research, told the South China Morning Post that India should turn to China for help

.

“Neighboring countries’ help to neighboring countries is not only crucial for controlling the epidemic, but also provides an opportunity for the two countries to bridge their differences.”《 Novel coronavirus pneumonia has been a pressing matter of the moment after the global epidemic

.

The Singapore United Morning Post has commented that geopolitical factors have been interfering with the epidemic

.

Now it is imperative to help India control the epidemic as soon as possible

.

If the epidemic is repeatedly robbed by geopolitics, the global epidemic front will be longer

.

Source: cnews.com reviewed by Yang Liang and Yang Jun   Lu Jian editor: he Yuxin  •  end  •  Looking back on the past, building the fulcrum of high skilled talents in Fengxian’s new development pattern! The central group of the district Party committee held a study (expansion) meeting

.

Lengjiang Yuxiang is very warm today

.

Blood, enthusiasm and enthusiasm have become great love

.

On the eve of marriage, the bridegroom was arrested for doing this! envy! There is a “private park” in Nanqiao village, which is only open to the residents of the village!.

.